Alpenglow Biosciences is excited to be part of EACR 2025, where cutting-edge cancer research meets next-generation technology. Our AI-driven 3D tissue imaging platform captures entire tissue volumes without slicing, preserving spatial context and eliminating distortion.

Meet with us at EACR to discover how full-volume imaging and quantitative spatial analysis can accelerate your oncology research. From tissue to insight, our end-to-end platform reveals what 2D histology misses—unlocking deeper biological understanding and faster decision-making.

Whether you're focused on tumor microenvironment, vascular networks, or cellular architecture, our approach brings unprecedented clarity to complex systems. Let’s explore how 3D spatial biology can drive your next breakthrough.